![Christina Cameron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina Cameron
Investor Relations Contact chez
ANTIBE THERAPEUTICS INC.
Profil
Christina Cameron is currently Director-Investor Relations at Medicago, Inc. and Vice President-Investor Relations at Antibe Therapeutics, Inc. Former roles include Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026, and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
Education includes an undergraduate degree from Wilfrid Laurier University.
Postes actifs de Christina Cameron
| Sociétés | Poste | Début |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Investor Relations Contact | - |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Contact | - |
Anciens postes connus de Christina Cameron
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Investor Relations Contact | - |
Formation de Christina Cameron
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
 Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
 Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
